HomeVIRP • EPA
add
Virbac SA
Previous close
€297.50
Day range
€290.30 - €306.00
Year range
€249.70 - €400.00
Market cap
2.57B EUR
Avg Volume
6.11K
P/E ratio
17.65
Dividend yield
-
Primary exchange
EPA
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 347.22M | 9.12% |
Operating expense | 190.43M | 14.79% |
Net income | 25.31M | 9.43% |
Net profit margin | 7.29 | 0.28% |
Earnings per share | — | — |
EBITDA | 51.68M | 7.87% |
Effective tax rate | 22.95% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 153.91M | -13.73% |
Total assets | 1.85B | 26.98% |
Total liabilities | 805.12M | 47.51% |
Total equity | 1.04B | — |
Shares outstanding | 8.37M | — |
Price to book | 2.39 | — |
Return on assets | 5.25% | — |
Return on capital | 7.15% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 25.31M | 9.43% |
Cash from operations | 83.82M | 64.16% |
Cash from investing | -30.72M | 31.48% |
Cash from financing | -57.85M | -174.94% |
Net change in cash | 24.52M | 281.63% |
Free cash flow | 12.19M | -25.40% |
About
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick.
The company is the 6th the largest veterinarian pharmaceutical group with a turnover of 1,397 million euros in 2024. The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME. Wikipedia
Founded
1968
Headquarters
Website
Employees
5,620
